22nd Annual PET/CT meeting

Radiologist and nuclear medicine physician from Zurich and working in Canada, his clinical research focus is combining molecular imaging strategies, such as allowing physicians to assess the profusion, function and viability of blood flow at the same time. His research areas are Hybrid Imaging (PET/CT, PET/MR, SPECT/CT), Oncology Imaging, Cardiovascular Imaging and pre-clinical animal imaging.

Rod is a Professor of Medicine and Radiology at the University of Melbourne and Director of the Centre for Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, Australia. Peter Mac installed the first PET/CT outside Europe and North America in 2001 and now has an experience of over 75,000 PET studies performed in the facility founded by him in 1996. He has pioneered the use of this modality in the assessment of cancer and has introduced a number of novel PET tracers.  His group established the first pre-clinical PET imaging facility in Australia in 2002 and has a strong focus on translational research and drug development. He holds numerous national and international research grants and is Editor-in-Chief of Cancer Imaging, as well as serving on 8 other editorial boards including Endocrine-Related Cancer. He has over 400 peer-reviewed publications. A major focus of his clinical research has been to assess the impact of PET on patient management and prognostic stratification. In addition, he is actively involved in radionuclide therapy with a major focus on neuroendocrine tumours. He was the recipient of a major translational research grant from the Victorian Cancer Agency to develop new diagnostic and therapeutic approaches for this group of diseases. He received a prestigious National Health and Medical Research Council Program Grant in 2013 and an NHMRC Practitioner Fellowship in 2015. He was also induced as a Fellow of the Australian Academy of Health and Medical Science in 2015. In 2016 he will Chair the 4th Theranostics World Congress in Melbourne.